Name | 8-oxo-5-(trideuteriomethoxy)-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid |
---|---|
Synonyms |
1,3-Dioxolo[4,5-g]quinoline-7-carboxylic acid, 5,8-dihydro-5-(methyl-d-oxy)-8-oxo-
5-[(H)Methyloxy]-8-oxo-5,8-dihydro[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid 5,8-Dihydro-5-methoxy-d3-8-oxo-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid Miloxacin-d3 |
Description | Miloxacin-d3 is the deuterium labeled Miloxacin. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 460.9±55.0 °C at 760 mmHg |
Molecular Formula | C12H6D3NO6 |
Molecular Weight | 266.221 |
Flash Point | 232.5±31.5 °C |
Exact Mass | 266.061829 |
PSA | 86.99000 |
LogP | 1.34 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.689 |
Symbol |
GHS07, GHS08 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335-H361 |
Precautionary Statements | P261-P281-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xn |
Risk Phrases | 63-36/37/38 |
Safety Phrases | 26-36/37 |
RIDADR | NONH for all modes of transport |